Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

News Feature: Mood Swings

As antidepressants come under scrutiny for their suspected link to suicide, skeptics question how safe and effective the 'miracle drugs' really are. But as Apoorva Mandavilli discovers, the prospects for a better alternative are downright depressing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors

Related links

Related links

Related links in Nature Research

Analysis highlights suicide risk of antidepressants

Courts crack down on drug marketing strategies

Antidepressant reputation falls to new lows

Trial analysis questions use of antidepressants in children

Web focus - Antidepressants

Related external links

FDA summary of pediatric drugs

FDA advisory meeting

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandavilli, A. News Feature: Mood Swings. Nat Med 10, 1010–1012 (2004). https://doi.org/10.1038/nm1004-1010

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1004-1010

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing